Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anas Shamsi
Observed names:
A. Shamsi,
Shamsi, Anas
Institutions:
Iran University of Medical Sciences,
Ajman University,
Jamia Millia Islamia
Observed institutions:
Chulalongkorn University,
Iran University of Medical Sciences,
Aligarh Muslim University,
Ajman University,
Urmia University,
Jamia Millia Islamia,
Jazan University
show all 7
ORCID:
0000-0001-7055-7056
Observed ORCID:
0000-0001-7055-7056
OpenAlex ID:
A5024897337
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
2024
·
Mohsen Naghavi
, Stein Emil Vollset
, et al.
·
The Lancet
·
5,564
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
2024
·
Valery L Feigin
, Melsew Dagne Abate
, et al.
·
The Lancet Neurology
·
2,727
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
2025
·
Marie Ng
, Emmanuela Gakidou
, et al.
·
The Lancet
·
1,730
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025
·
Simon I Hay
, Kanyin Liane Ong
, et al.
·
The Lancet
·
1,376
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025
·
Mohsen Naghavi
, Hmwe Hmwe Kyu
, et al.
·
The Lancet
·
940
PDF
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
2025
·
Austin E Schumacher
, Peng Zheng
, et al.
·
The Lancet
·
319
Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
2024
·
Austin Carter
, Meixin Zhang
, et al.
·
The Lancet HIV
·
286
PDF
Role of polyphenols in combating Type 2 Diabetes and insulin resistance
2022
·
Moyad Shahwan
, Fahad Alhumaydhi
, et al.
·
International Journal of Biological Macromolecules
·
243
Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
2026
·
Kayleigh Bhangdia
, Miranda L May
, et al.
·
The Lancet Oncology
·
224
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023
2025
·
Emily Haeuser
, Sam Byrne
, et al.
·
The Lancet
·
221
FNDC5/Irisin: Physiology and Pathophysiology
2022
·
Rashid Waseem
, Anas Shamsi
, et al.
·
Molecules
·
212
PDF
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
2024
·
Dana Bryazka
, Marissa B Reitsma
, et al.
·
The Lancet Public Health
·
200
Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy
2021
·
Saleha Anwar
, Anas Shamsi
, et al.
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
193
Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
2025
·
Fiona B Bennitt
, Sarah Wozniak
, et al.
·
The Lancet
·
180
Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025
·
Sarah Brooke Sirota
, Rose Grace Bender
, et al.
·
The Lancet Infectious Diseases
·
175
Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
2024
·
Peter J Leary
, Megan Lindstrom
, et al.
·
The Lancet Respiratory Medicine
·
174
Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition
2020
·
Saleha Anwar
, Anas Shamsi
, et al.
·
Scientific Reports
·
173
PDF
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy
2020
·
Anas Shamsi
, Taj Mohammad
, et al.
·
Bioscience Reports
·
172
Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies
2020
·
Taj Mohammad
, Shiza Siddiqui
, et al.
·
Molecules
·
165
PDF
Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer
2022
·
Manzar Alam
, Shoaib Alam
, et al.
·
Frontiers in Oncology
·
138
PDF
Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies
2024
·
Manzar Alam
, Mehak Gulzar
, et al.
·
Molecular Biomedicine
·
120
PDF
Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6
2020
·
Mohd Yousuf
, Anas Shamsi
, et al.
·
International Journal of Molecular Sciences
·
120
PDF
Potential drug targets of SARS-CoV-2: From genomics to therapeutics
2021
·
Anas Shamsi
, Taj Mohammad
, et al.
·
International Journal of Biological Macromolecules
·
118
PDF
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
2020
·
Anas Shamsi
, Saleha Anwar
, et al.
·
Biomolecules
·
118
PDF
Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy
2020
·
Taj Mohammad
, Anas Shamsi
, et al.
·
Virus Research
·
105
Show more works
View as search
Works count:
272
Citation count:
20,360
H-index:
50
I10-index:
138
Year
Topic
Type